Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Medmira Inc (MIR) Common Stock

Sell:0.26 CAD Buy:0.26 CAD Change: No change
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.26 CAD
Buy:0.26 CAD
Change: No change
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.26 CAD
Buy:0.26 CAD
Change: No change
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

MedMira Inc. is a biotechnology company. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company operates through the rapid diagnostic products and services segment. The Rapid Vertical Flow (RVF) Technology platform is the basis for the Company's line of rapid tests. Its research focuses on specific areas of the diagnostics market, such as rapid, point-of-care and in vitro sectors. The RVF technology platform includes a three component system: a test cartridge, multi-function buffer and InstantGold Cap. Its technology can be applied in healthcare, research and industrial markets. It offers rapid tests for testing serum, plasma or whole blood specimens. The Company's tests are sold under brands, including Reveal, Multiplo and Miriad. The Company offers rapid tests for human immunodeficiency virus (HIV), Hepatitis B and C, and syphilis.

Contact details

Address:
155 Chain Lake Dr.,, Suite 1
HALIFAX
B3S 1B3
Canada
Telephone:
+1 (902) 4501588
Website:
medmira.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
MIR
ISIN:
CA58501R1029
Market cap:
174.47 million CAD
Shares in issue:
658.36 million
Sector:
Health Care Equipment
Exchange:
Canadian Venture Exchange
Country:
Canada
Currency:
Canadian dollars
Indices:
n/a

Key personnel

  • Hermes Chan
    Chief Executive Officer, Director
  • Markus Meile
    Chief Financial Officer
  • Sing Chan
    Chief Operating Officer
  • Robyn Cook
    Chief Corporate Officer, Corporate Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.